Nanjing Pharmaceutical Company Overview
Share Price
$0.60
(As of Tuesday Closing)
Nanjing Pharmaceutical Company General Information
Description
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Nanjing Pharmaceutical Company Stock Performance
(As of Tuesday closing)
| Stock Price |
Previous Close |
52 wk Range |
Market Cap |
Shares |
Average Volume |
EPS |
| $0.60 |
$0.59 |
$0.56 - $0.80 |
$625M |
1.04B |
9M |
$0.05 |
Nanjing Pharmaceutical Company Financials Summary
In Thousands,
USD
|
TTM
31-Mar-2020
|
FY 2019
31-Dec-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
| EV |
870,888 |
1,239,996 |
1,063,495 |
1,441,885 |
| Revenue |
5,341,880 |
5,377,938 |
4,731,931 |
4,263,167 |
| EBITDA |
134,482 |
157,092 |
139,215 |
115,592 |
| Net Income |
50,346 |
50,213 |
39,952 |
34,395 |
| Total Assets |
3,412,834 |
3,139,372 |
2,842,683 |
2,538,991 |
| Total Debt |
888,643 |
451,635 |
441,212 |
793,727 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Nanjing Pharmaceutical Company Valuation & Funding
| Deal Type |
Date |
Amount |
Valuation/
EBITDA |
Post-Val |
Status |
Debt |
This information is available in the PitchBook Platform. To explore Nanjing Pharmaceutical Company‘s full profile, request access.
Request a free trial
Nanjing Pharmaceutical Company Executive Team (4)
| Name |
Title |
Board Seat |
Contact Info |
| Yu Liang |
President & Director |
|
|
| Wei Li |
Chief Financial Officer |
|
|
| Xiao Jiang |
Chief Operating Officer & Secretary |
|
|
| Jian Tang |
Chief Quality Control Officer |
|
|
Nanjing Pharmaceutical Company Investors
| Investor Name |
Investor Type |
Holding |
Investor Since |
Participating Rounds |
Contact Info |
This information is available in the PitchBook Platform. To explore Nanjing Pharmaceutical Company‘s full profile, request access.
Request a free trial